Acnecutan

Quick links to important sections

Acnecutan

Selected form

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Acnecutan

What is Acnecutan?

Property Description
Active Ingredient Isotretinoin
Form Oral Soft Capsules
Pharmacological Class Retinoid (Vitamin A derivative)
Common Use Severe, refractory nodular acne
Origin Synthetic

What is Acnecutan (Isotretinoin)?

Acnecutan is a powerful, prescription-only systemic medication used for treating the most severe and difficult-to-manage forms of acne. Its Active Ingredient is Isotretinoin, and it belongs to the Pharmacological Class of retinoids. This medicine is administered orally as soft capsules, which are designed for consistent systemic absorption.

Isotretinoin is a synthetic compound derived from Vitamin A (retinol). It is recognized globally for its effectiveness as a treatment for severe acne that has not responded to other medications. This confirms that Acnecutan is intended only for people with serious acne who have tried standard treatments without success.


What is the Therapeutic Purpose of Acnecutan?

The primary therapeutic purpose of Acnecutan is the complete and sustained resolution of severe, disfiguring acne, specifically nodular (cystic) or conglobate acne. It is considered a last-line systemic treatment because of its potency in addressing the root causes of the most aggressive acne types.

Its therapeutic goal is to induce long-term remission, which is critical for preventing permanent scarring and minimizing the significant psychological impact associated with chronic severe acne. This drug has an established clinical role in clearing acne that is at risk of causing permanent scarring.


How Does Acnecutan Fit into Acne Treatment?

Acnecutan is strategically positioned as a definitive, high-impact oral treatment option to be deployed only when moderate and mild acne management strategies have proven inadequate. It is not indicated for routine or less severe cases of acne.

Before prescribing this medication, dermatologists must confirm that the acne severity warrants a systemic retinoid. The medicine's specific role in the treatment sequence is to deliver a complete, sustained resolution for the most challenging cases, thereby preventing further disease progression and chronic recurrence.

What side effects are possible with Acnecutan?

Acnecutan (isotretinoin) is a potent medication used to treat severe acne, and its use requires careful consideration of potential side effects and strict safety precautions.

Severe Safety Warnings

  • Pregnancy and Birth Defects: Acnecutan is highly teratogenic (causes severe birth defects). It is strictly contraindicated during pregnancy and in women who may become pregnant. Effective contraception (two reliable forms) must be used for at least one month before, throughout the course of treatment, and for one month after stopping the medication. Even a single dose can cause severe birth defects, miscarriage, or premature birth.
  • Mental Health: Changes in mood, including depression, anxiety, irritability, and, rarely, suicidal ideation or behavior, have been reported. Patients and family members should monitor closely for any changes in mood or behavior, and medical attention must be sought immediately if they occur.

Common Side Effects

The most frequent side effects are related to the drug's effect on the skin and mucous membranes. These are generally dose-dependent and reversible upon stopping treatment:

System Common Effects
Skin/Mucosa Dry skin and eyes, chapped lips (cheilitis), nasal dryness and nosebleeds, sun sensitivity (photosensitivity)
Musculoskeletal Joint pain (arthralgia), muscle pain (myalgia), especially with intense physical activity

Less Common but Serious Effects

  • Liver and Lipids: The drug can cause temporary, sometimes significant, changes in liver enzyme levels and blood lipid levels (triglycerides and cholesterol). Regular blood tests are necessary to monitor these values.
  • Neurological: Rarely, increased pressure inside the skull (pseudotumor cerebri) has been reported, sometimes presenting as severe headache, blurred vision, dizziness, nausea, or vomiting. Concomitant use with tetracyclines is contraindicated due to increased risk.
  • Gastrointestinal: Cases of inflammatory bowel disease (IBD) have been reported, requiring immediate cessation of the drug if symptoms like severe abdominal pain or rectal bleeding occur.

Patients must avoid waxing, dermabrasion, and laser treatments during therapy and for at least six months afterward due to the risk of scarring.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for an overdose of Acnecutan (Isotretinoin) outlines specific manifestations and strictly mandated emergency actions.

Documented Overdose Manifestations

Acute over-ingestion of Acnecutan typically leads to signs of acute retinoid toxicity. Documented manifestations, consistent with effects of high systemic exposure as listed in regulatory summaries, include Vomiting, Headache, Dizziness, Abdominal pain, Facial flushing, Cheilosis (severe chapped lips), and Ataxia (loss of coordination).

Serious Outcomes and Management Protocol

Overexposure carries the risk of severe outcomes, primarily due to the drug’s classification as a retinoid. Serious, high-exposure effects documented in regulatory labeling include symptoms resembling hypervitaminosis A and the potential for benign intracranial hypertension (Pseudotumor cerebri). Acute pancreatitis has also been reported as a risk associated with high systemic exposure. The officially defined management protocol is symptomatic and supportive treatment; no specific antidote is known or listed in regulatory labeling. Acute overdose symptoms may rapidly resolve without specific intervention.

Mandated Emergency Action

In the event of suspected or known over-ingestion, the official regulatory instruction from government health authorities is to contact a poison control center or emergency room at once. Urgent medical help is required immediately upon the consumption of any amount exceeding the prescribed dose, as the condition requires professional assessment.

Therapeutic Uses of Acnecutan

Acnecutan (Isotretinoin) is commonly used in conditions marked by increased physiological stress, relevant to severe and refractory forms of acne. It is applied across domains where additional symptomatic support is needed after prior conventional therapies have been unsuccessful. This medication is used for severe recalcitrant nodular acne that has not been helped by other treatments, such as antibiotics.

Primary Symptomatic Focus

This medication is applied across therapeutic domains where relief is needed for symptoms related to inflammatory or irritative states, specifically the deep, painful nodular and cystic lesions that typify severe acne. It is considered relevant for easing symptoms that create noticeable physiological strain. The primary benefit contributes to easing the overall symptom load by supporting symptomatic management, especially when the condition is at risk of permanent scarring.

Indications commonly addressed include severe nodular acne, acne conglobata, and chronic disease unresponsive to adequate conventional treatment.

“The therapeutic use supports patients dealing with persistent, disfiguring symptoms, applied in settings where symptoms become momentarily overwhelming.”

Strategic Clinical Role

Acnecutan is commonly used across conditions presenting with acute or disruptive episodes and is relevant in cases that are refractory (unresponsive) to adequate conventional treatments. This medicine provides support that helps ease the overall symptom burden, and is commonly used to help with symptoms that interfere with daily functioning. This treatment is applied in addressing the severe symptoms and contributes to improved comfort, especially where the symptoms are highly visible and interfere with daily functioning.


Quick Fact: Relief for Refractory Symptoms

This medication is applied when prior treatment with systemic antibiotics and other conventional methods has proven insufficient for controlling the severe, destructive lesions.

Regulatory References

  1. NIH MedlinePlus overview of Isotretinoin

Eligibility and Restrictions for Use

Official Eligibility Profile: Who Can and Cannot Use Acnecutan

The eligibility to use Acnecutan (Isotretinoin) is strictly controlled by regulatory authorities, primarily due to the drug's absolute teratogenic risk.

Category Official Regulatory Status
Populations for whom use is allowed Patients 12 years of age and older with severe recalcitrant nodular acne unresponsive to conventional therapy, including systemic antibiotics.
Populations for whom use is contraindicated Females who are, or may become, pregnant or who are breastfeeding. Patients with hepatic insufficiency, pre-existing hypervitaminosis A, markedly elevated blood lipid levels, or hypersensitivity to isotretinoin or its components (e.g., soya bean oil, parabens).

Eligibility-Related Restrictions

| Age-related eligibility rules | Not recommended in children under 12 years of age or before puberty; use in older adults is generally not limited by age-specific problems in studies to date. | | Condition-specific eligibility rules | Contraindicated for concomitant use with tetracyclines. Use requires caution and close monitoring in patients with a history of diabetes, lipid metabolism disorder, or certain psychiatric disorders. | | Pregnancy and lactation eligibility status | Contraindicated in both pregnancy and lactation. Females of childbearing potential are only eligible if they comply with a mandatory Pregnancy Prevention Programme (e.g., iPLEDGE REMS) requiring specific pregnancy testing and the use of two forms of contraception.


Connection to the overall eligibility profile:

Governmental regulatory documents define who can and cannot use this medicine by establishing absolute contraindications for pregnancy and specific organ/metabolic disorders, and by implementing a Restricted Distribution Program (REMS). This regulatory structure effectively reserves the drug for patients with severe disease who are not pregnant and who can demonstrate full compliance with all mandated monitoring and contraception rules.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Acnecutan (isotretinoin) is a retinoid and can interact with several other medicines and supplements. These interactions can increase the risk of serious side effects or reduce the effectiveness of co-administered treatments. Consultation with a healthcare provider is necessary before combining Acnecutan with any other product.

Interacting Product Category Nature of Interaction and Risk
Tetracycline Antibiotics (e.g., doxycycline, minocycline) Concomitant use must be avoided as it may significantly increase the risk of pseudotumor cerebri (benign intracranial hypertension—increased pressure in the brain).
Vitamin A Preparations and Supplements Concurrent use is restricted due to the risk of cumulative toxicity (hypervitaminosis A), which can amplify the side effects of Acnecutan.
Progestin-Only Birth Control Pills (Mini-Pills) These contraceptives may be less effective when taken with Acnecutan. Patients who can become pregnant are required to use two reliable forms of birth control, and progestin-only pills are not considered a reliable form when used alone.
Phenytoin (for seizures) and Systemic Corticosteroids (Steroids) Co-administration may result in cumulative bone effects, potentially increasing the risk of bone mineral density loss or osteoporosis.

Patients should inform their healthcare team about all prescription medications, over-the-counter products, vitamins, and herbal supplements being taken prior to and during treatment.

Mechanism of Action

Acnecutan is a retinoid that functions by targeting nuclear and cytosolic receptors RAR and RXR. It specifically binds to and acts as an agonist for the RARgamma subtype, which is expressed predominantly in the skin. RARgamma binding induces heterodimerization with RXR and subsequent translocation to the nucleus, where the complex binds to retinoic acid response elements (RARE) on the DNA. This activation initiates a transcriptional cascade, leading to the downregulation of genes responsible for sebocyte proliferation and differentiation. This decreased sebogenesis and subsequent modulation of keratinocyte behavior collectively regulate oil production and keratinization, resulting in a decreased formation of keratinous impactions within the follicle. Furthermore, the compound mediates the modulation of T-cell and macrophage activity, influencing the inflammatory signaling cascade and supporting dermal homeostasis through gene expression control.

Dosage and Administration Information

Acnecutan (Isotretinoin) is administered systemically via the oral route as soft capsules. The dosage is determined by the patient's body weight and is generally initiated at a range of 0.5 to 1 mg/kg per day. In cases of very severe acne with scarring or trunk involvement, the dose may be adjusted up to a maximum of 2 mg/kg per day.

To ensure consistent therapeutic delivery, the total daily dose is required to be taken in two equally divided doses. This regimen is prescribed toward a specific cumulative dose target, often established between 120 mg/kg and 150 mg/kg, which is considered necessary for achieving sustained resolution.

Regarding physical intake, the capsules must be swallowed whole with a full glass of liquid to mitigate the risk of esophageal irritation. Furthermore, the administration of many conventional isotretinoin formulations must be coordinated with a meal because the drug's absorption is significantly enhanced by fat content.

A single course of therapy typically lasts 15 to 20 weeks. If the condition warrants a second course, it should not commence until a minimum of 8 weeks has passed since the completion of the first, allowing for a full assessment of treatment results. The medication is approved for adolescents 12 years of age and older, who follow the same weight-based dosing rules. If a dose is missed, the dose must be skipped, and the patient should not take two doses at the same time to compensate.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Acnecutan


Evidence for Use in Severe Recalcitrant Nodular Acne

The clinical evaluation of Acnecutan has primarily centered on its use in severe nodular acne and acne conglobata, which are conditions characterized by fluctuating or episodic manifestations and are refractory to conventional treatment. The research has explored how symptoms change over time using several types of studies, including Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews of trial data. The research examined populations that presented with a defined range of lesion counts and severity scores.

The RCTs were conducted during periods of increased symptom activity, and the medication was evaluated against placebo or other conventional treatments. The focus is on the study designs, with research monitoring primary outcomes such as lesion count changes, severity scale scores, and the potential for change in outcomes linked to inflammatory or irritative states in patients with severe, unresponsive acne. Studies monitored how outcomes related to physical discomfort evolved during the intermediate-term active treatment period, typically lasting four to six months.

Research provides insight into symptom patterns across the observed populations. However, results apply only to the specific populations studied, and the evidence quality varies across studies, which can complicate the full synthesis of data. Comparative evidence against some newer therapies remains limited.


Long-Term Studies and Durability of Response

Beyond the initial active treatment phase, research has been applied in observational settings evaluating long-term patient status. These observational cohort studies often tracked patients for periods ranging from one to two years, and sometimes up to five years, following the completion of therapy. The primary focus of these long-term studies was observing acne relapse rates and how symptoms evolved in the observed populations over time.

Studies report how symptoms evolved in the observed populations, and post-treatment status was observed in some studies to vary, which indicates evidence quality varies across studies. This reflects that protocols for defining and tracking relapse differed across research settings. Certainty remains low regarding the consistency of long-term outcomes, as long-term effects are not fully established through head-to-head comparative trials.


Research Gaps and Areas of Uncertainty

The research landscape highlights key areas where certainty remains low or data are still emerging. One significant gap is the heterogeneity in the reported long-term outcomes; follow-up durations were limited or inconsistent across many of the observational studies. Comparative evidence is lacking against all alternative systemic treatments, particularly in long-term observational settings. Overall, the research provides context but not individual predictions, and the evidence contributes to understanding symptom patterns related to the specific conditions under which they were conducted.

Key Studies & References Isotretinoin Oral: MedlinePlus Drug Information (Uses and Indications)

Frequently Asked Questions (FAQ)

Common questions about Acnecutan (FAQ)

Q: What is the main difference between Acnecutan and other acne treatments I see advertised?

A: Official product information describes Acnecutan as a potent, systemic retinoid, meaning it is taken orally and works throughout the body. This medication is reserved for severe and difficult-to-manage forms of acne that have not responded to conventional therapies. This classification as a potent systemic retinoid establishes its role, which differs from topical or milder oral treatments.

Q: Is it true that Acnecutan can permanently clear up acne?

A: The therapeutic intent of the treatment is to achieve sustained resolution of severe acne, leading to long-term remission. Studies have examined the durability of the response over time following treatment. Official research indicates that post-treatment status was observed to vary across patient populations.

Q: Is it common for acne to return after finishing a course of Acnecutan?

A: Observational research studies have tracked acne relapse rates in the patient populations studied. If the condition warrants it, regulatory guidelines outline that a second course of therapy may be considered. A second course is not to be started until a minimum waiting period has passed.

Q: What research exists about using Acnecutan for adult acne?

A: The medication is approved for patients 12 years of age and older. While the core research is focused on severe, refractory nodular acne, the study populations have included individuals across various age ranges, including adults.

Q: Does Acnecutan affect your mood or cause feelings of sadness?

A: Official safety warnings describe that changes in mood, including depression, anxiety, irritability, and, rarely, suicidal ideation or behavior, have been reported by people taking this medication. Official documentation notes that patients and family members should monitor closely for any changes in mood or behavior.

Q: How long after stopping Acnecutan can I start planning a pregnancy?

A: Women must use effective contraception for at least one full month before, throughout the course of treatment, and for one month after stopping the medication. This mandatory one-month waiting period ensures full compliance with the Pregnancy Prevention Programme.

Q: Are there any non-prescription creams or supplements that should be avoided while on Acnecutan?

A: Patients should avoid the concurrent use of Vitamin A preparations due to the risk of cumulative toxicity, which can amplify side effects. Official guidelines note that concurrent use of this drug with other topical (applied to the skin) acne treatments may cause excessive irritation.

Q: Can men also have side effects related to reproductive health when taking Acnecutan?

A: Post-marketing reports related to the use of this drug have included instances of sexual dysfunction, such as decreased libido (sex drive) and erectile dysfunction, in male patients.

Q: Why do doctors require monthly blood tests for people taking Acnecutan?

A: Regular blood tests are required to monitor for potential, sometimes significant, changes in liver enzyme levels and blood lipid levels (fats like triglycerides and cholesterol). These tests are part of the required regulatory monitoring established by risk management programs to assess changes throughout the treatment period.

Q: Do I need to change my diet while taking Acnecutan?

A: Official administration instructions require that the capsules be taken with a meal that contains fat. This is because the presence of fat significantly increases the body's absorption of the medication. No other major dietary changes are explicitly mandated.

Q: Is Acnecutan used to treat things other than severe acne?

A: The official therapeutic purpose described in regulatory documents is the complete and sustained resolution of severe, disfiguring acne that has not responded to other conventional systemic or topical therapies. This defines its primary approved use.

Q: What do official documents say about Acnecutan and hair loss?

A: Official information lists thinning of the hair as a reported adverse effect that has been observed in some patients. In rare instances, this effect has persisted after the medication was stopped.

Q: What is the difference between a generic version and the brand-name Acnecutan?

A: The active ingredient in Acnecutan is isotretinoin. There are multiple isotretinoin products on the market, including generic versions. Regulatory agencies require all versions, whether brand-name or generic, to meet the same official standards for the drug’s information and safety profile.

Q: What are the official guidelines regarding using Acnecutan and St. John's wort?

A: Patients who can become pregnant are specifically cautioned to avoid the use of the herbal supplement St. John's Wort. This is a major concern because of the drug’s significant risk of severe birth defects, as the supplement may reduce the effectiveness of hormonal contraceptives.

Q: Why is the drug required to be dispensed with a risk management program?

A: Due to its high risk of causing severe birth defects, the drug is subject to a Restricted Distribution Program (e.g., REMS). This program implements mandated adherence to monitoring, testing, and prevention requirements for patients and prescribers.

Q: Does the strength of the capsule affect the types of side effects?

A: Official documentation notes that side effects of the medication are generally dose-dependent. This means that the chance or potential severity of experiencing some side effects may increase with higher daily doses.

How should Acnecutan be stored and disposed of?

How to Store and Dispose of Acnecutan (Isotretinoin)

Acnecutan (isotretinoin) must be stored at a strictly defined Controlled Room Temperature of 20 C to 25 C (68 F to 77 F), with temporary excursions permitted up to 30 C (86 F). The medication must be kept in its original container, which should be tightly closed to maintain product stability.

Protection and Safety

The capsules are sensitive and must be protected from light and excessive moisture. All medication must be stored out of the reach and sight of children.

Disposal

Unused or expired Acnecutan should not be flushed down the toilet or placed in household trash. Disposal must be handled according to local regulatory guidelines, typically by utilizing a designated drug take-back program or returning it to a pharmacy.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Acnecutan found in:

A-Z Index: